FDA Recalls List – September 17, 2014
This article was originally published in The Gray Sheet
The agency’s Sept. 17 enforcement report includes class II recall actions from CooperSurgical, Siemens and Stryker.
You may also be interested in...
At the end of the Brexit transition period, the UK will be charting its own course through the often choppy seas of medicines regulation. While it plans to retain the existing EU rules that have been transposed into domestic legislation, it also wants the freedom to tailor its regulations in areas like clinical trials, advanced therapies and product labeling.
Health technology assessment body NICE is consulting on draft guidance that recommends Axonics' device for overactive bladder.